{"name":"Sankyo Pharma Gmbh","slug":"sankyo-pharma-gmbh","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Furosemide oral tablets","genericName":"Furosemide oral tablets","slug":"furosemide-oral-tablets","indication":"Edema associated with congestive heart failure","status":"phase_3"}]}],"pipeline":[{"name":"Furosemide oral tablets","genericName":"Furosemide oral tablets","slug":"furosemide-oral-tablets","phase":"phase_3","mechanism":"Furosemide inhibits sodium and chloride reabsorption in the loop of Henle, promoting diuresis and reducing fluid overload.","indications":["Edema associated with congestive heart failure","Edema associated with hepatic cirrhosis","Edema associated with renal disease","Hypertension"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiogJBVV95cUxOVUpIQjZFNFZ5RTBPSENNQ19mZ0pka3Y5Unk4aDEtRXlCQkxZZUpvYm1KWEhLbUUteFNYZ1BnRmNtZkpaZ2pMYmVvNjRjdjBJMmVveDRaTjQ2LVN1SmpuaUZzS1hCZUdMVWhDVjdQNl84Mko0dUExMXpuQXVadnpQMldCZHBqUlV2Q2stcVRoQW1zYWd1MWFNRVMwSVR0Y3Q3M1BqRVNoMkFLUlVxdUNTMm1mTkhCUTZxUmp0amhuWHljTVgwcnRjOFE2TVdON3o5SkZGWWJ2ODN4QllpSWhLWHlSVHpTWmpMZ3FNb0M2ZXA1N2RYV19vRFNFaDJxUndIZUZCblJvY0NVTFRMRERKNXh4WWkza1pCSXR2OVVwNW95Zw?oc=5","date":"2026-03-05","type":"deal","source":"businesswire.com","summary":"GAIA and Daiichi Sankyo Europe Enter Exclusive Partnership to Launch Next-Generation Digital Therapeutic for Cardiovascular Care in Europe. - businesswire.com","headline":"GAIA and Daiichi Sankyo Europe Enter Exclusive Partnership to Launch Next-Generation Digital Therapeutic for Cardiovascu","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAJBVV95cUxQOWZnSF9WaEN2TWRQUHZkSmc3Um5VaEk0c2NMamNhSl9oZWJPSUZnSUVjcUdlbU4xUzZtdFZIelQ3V0hhV0RWUWM3UGp3U216bEJGWlhIU19oRE5BOVp0Umx1dEY5Z1JSY25fOUtXS0NSWlk3Y2wwU2dKMVNvN1h4dHU4QXVFYWhiWFRJMERoTkpZTmlwOVRXMjA5YUtQQ3lyLTdvZXNZN3o5OXlXcHZ1OUpLUGIwbmxNSmlMZUw5MG8yMEdnLTlrWndSekhkNnhWbWdnZTdZX0dRajlobERRRVpuWnJ0bG44anZfZnJQZDBJeWlKY29ua3ViMmFYUUhKNXB0djhiRkk?oc=5","date":"2026-01-07","type":"pipeline","source":"businesswire.com","summary":"Daiichi Sankyo and GENESIS Pharma Enter Exclusive Agreement for VANFLYTA - businesswire.com","headline":"Daiichi Sankyo and GENESIS Pharma Enter Exclusive Agreement for VANFLYTA","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5AFBVV95cUxQVDhXeks2aC1JanhwZVdxeEFaYklicjRCLVVVQlhjY185LS1iUVN4enFBb2FZcnd6YWY4dkxKVEdObk40ck5QcjFqYVpUMHlnTk5qNmtndC1QSlRfNWRINTVmV2dhbWt3TERqOVRBMU1vRS1nN3dJMFhpcXQzVHhFanhUYVFOZGltN0twXzJoeHVodUJvZHBGNWQyQy1aOXFLeV9OOF9jTkk4ZTF4VVhjcFhwWnFXSUt2WllNbnJqM191U0RxZTQ3UUNxbXZfS0hiVDlnem02N3VYVEsyVjRVU1lVSWs?oc=5","date":"2025-09-02","type":"pipeline","source":"BioPharma APAC","summary":"Daiichi Sankyo Europe Initiates Development of Oral Triple Combination Tablets to Enhance LDL-C Management - BioPharma APAC","headline":"Daiichi Sankyo Europe Initiates Development of Oral Triple Combination Tablets to Enhance LDL-C Management","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3gFBVV95cUxPOFpjQ2gxLWpPdk51NXVETlJjanFUc3ZtOWp6cmR1TkR1OTg0czdFTkxZSVNXRVlDWWZHRHFkRXRCcTBlRGUtUkd5ZEowVWZGV2d6YlFKdFJqR3ppZkVUVUh6dWdVQXlaOVRkZWd6YV9jN2RhTTJpYm55Ty13d2g0RWQza0pjWUVibkxYWDFhaFJyemRUdU5EQTQwS19BeS02d3lvTy1zdHVOSzRHT3VjR05RTVFzSlpiWTZLYk5zS3d5aFprZncxYUJUM0E2bDVTMUxxZmpuZ19UQUN4OUE?oc=5","date":"2025-08-13","type":"trial","source":"Emerj Artificial Intelligence Research","summary":"AI as Enterprise-Wide Enabler of Clinical Trial Innovation - with Leaders from Medable, Takeda, Sanofi, Novartis, and Daiichi Sankyo - Emerj Artificial Intelligence Research","headline":"AI as Enterprise-Wide Enabler of Clinical Trial Innovation - with Leaders from Medable, Takeda, Sanofi, Novartis, and Da","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxPVkNvNmRMWGdwMmFib0k4WDJlWFcwZnV0Z3VsQUhFdE9VYVhtVVI0OGtPdVhXRzh5R1VJTS1DV3pIVzRjaUZneTZURk9aMlg1MFlyN0d5RXItU2E5RjJUMUoxbzFEQUR0UUhGSGtpdnZYMVpsOXFERC1uakxyMjFhajVzdzdYOG0yS0hReFY4MDNBNWhwOV9LZVFka3dXdmNvWEEwMUdJWkVmUDk0WGMtSGp3?oc=5","date":"2025-08-08","type":"regulatory","source":"Bloomberg.com","summary":"Top German Pharma Boehringer Wins US Approval for Cancer Drug - Bloomberg.com","headline":"Top German Pharma Boehringer Wins US Approval for Cancer Drug","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiZ0FVX3lxTE8xNnpKSEt0Qk51X0RTbTdhNFBmdlpJQ3lpWlN5VnZZNE95WXhBMmJwMGp0TzhBWjVkMWlsVHdFaDNJbGxMYUtOalpSWjVLUjB4WnRWa0M1OTJuN3hvOHVIeHBuRFh5UWc?oc=5","date":"2025-05-22","type":"pipeline","source":"Cleanroom Technology","summary":"High-tech for the future - Cleanroom Technology","headline":"High-tech for the future","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxOdmJ5QUJNOFp0WnIxdC1XU0ZxSmJyR3AyV1NuYnF6Sms5c2FodTc5R3JsWVl5TDlXWFhDMTFqV1ByYmtRSFZWOEdiWVlaSXRjbXlLaWc1a1J5QUlOdjFZLWJYaE9ydjdWVmRyY3Rfd2w4TU9KZ1A1TWdSbnBjTGJweWFUcTdmMFQ1bURrdkZneWhTLUZkdzc5dXJlaWJuN2Frc1Jyb2hRZEY1WHFKbEQw?oc=5","date":"2025-01-14","type":"deal","source":"Pharmaceutical Technology","summary":"Daiichi Sankyo buys solid tumour ADC from Glycotope for $132.5m - Pharmaceutical Technology","headline":"Daiichi Sankyo buys solid tumour ADC from Glycotope for $132.5m","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxQaklZbDY2aXAzOTB1OWhvQlVwb21qT1NHNVdnUGxBYnRLeTE2dTRWTlNNcjloTW1zLUFUVWQySFREMXljNEpZaF9QMTVOZXdpUWtJY2ZFZ0tQaUxQQXBWSzFoWTYtVGVLUVY5aTVIb3d0U01zVkxmM3N5ZGc1Uk0xeS1nYVhmbWpMNlR0b01yb0s2NHNkdHFOZExSYzZfczBOQUlRYktMQy1VWG5ZWUFVcHlVRnhXOVFRZEdyMnUzMFRSMFFUUEdr?oc=5","date":"2022-01-18","type":"pipeline","source":"Fierce Pharma","summary":"Daiichi Sankyo, with tighter focus on oncology, sells 8 aging US cardiovascular drugs to diversifying Cosette - Fierce Pharma","headline":"Daiichi Sankyo, with tighter focus on oncology, sells 8 aging US cardiovascular drugs to diversifying Cosette","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxQQ3RES0QySmcweGNyS1V4VGM0bDM5bkFEZUZXcDk0RTB1d19fa2NxWVdlbDBrTHNaV0lKQmJmV3J0M0hlMlNtVHVUZ0NMSk92LUtLWW5TczdILXJJSTBBcHVsOHFsQXJUNUxpcWJ4NHAxR25ZU0ZGTUdEd204bFl1WG5Kb2tWUFlvdVJySzFucU0tZHh4TF9YcmRXOUxnMEQ3VlVlNUk4Tlp0Y01sbTdSOHBfd1c?oc=5","date":"2021-02-22","type":"pipeline","source":"Fierce Biotech","summary":"Daiichi Sankyo poaches Kite's research lead Takeshita from parent Gilead - Fierce Biotech","headline":"Daiichi Sankyo poaches Kite's research lead Takeshita from parent Gilead","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxNanZkRTZyc2M4bWh2UFc1LTJETEtoRkEyUWN4dFJFSlpyTzZBWDBUWmMwdjlFSEg4VFNaTDZDS3FieFJBVTJWR2ZQWm5MS0FJbXV3R1dLUVgzVmRhN2hwYlhMYTc0SmVYV3NJWUs5Q2haaUdtTU9Ob0pxVkwzcjh2SGQ1WkNwRHk4eXN5RjU3eUg3enVLX3JCeE5ZWQ?oc=5","date":"2020-11-18","type":"trial","source":"JUVE Patent","summary":"Data exclusivity means market exclusivity for Daiichi Sankyo - JUVE Patent","headline":"Data exclusivity means market exclusivity for Daiichi Sankyo","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxNaUF3ekdXVURBT2VwYkI3UVNyU3R3b3d1ZXlLcEZaeEhEUXVESUIzUE5VMjhxQUlicldzSGJFZmwwZEZFd2lHeWFpMkt1bkFXZTctSEhyUmtJdlE1bGdjbkdtTVRkR1pHOGJjaTdHZ3ZwNmdNRnpBLWN5QmhPWWJnNEctRVBOSW5nWGJHZ0ZzT0U1bUhwdFRKYi1MSThLanFnVDFYWktiM2JaeWM?oc=5","date":"2018-06-20","type":"pipeline","source":"European Medical Journal","summary":"The Innovation, Care, and Compassion of Daiichi Sankyo – Part 1 - European Medical Journal","headline":"The Innovation, Care, and Compassion of Daiichi Sankyo – Part 1","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxPdVlkWmE2MzRNVGRHUFpoakRVbXZtWkNFNU5QTFZMUUdDOXRfaHJEMzhYZVVDT1Ytem5HYjNDcWpZeHdnQV8xeG9QTlpDcHVGdUtIbk5HbWpHR3BPX05lNS1RdmlXN1Y1OWE3RnVyNnRkQ0dHdHV3N3VhQnIwelFKYnNEUExTLTk2blRkQW1XUXZzNWhFNXlqOW85WUJHdw?oc=5","date":"2015-12-01","type":"pipeline","source":"Drug Target Review","summary":"Daiichi Sankyo to close research subsidiary U3 Pharma - Drug Target Review","headline":"Daiichi Sankyo to close research subsidiary U3 Pharma","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}